ARCHIVES

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

DeVita Says Payline Compression Leading to More Decisions By Staff On Funding

June 28, 1985

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994

Surveillance Following Surgery Sufficient in Stage I Seminoma

May 31, 2013

Cancer Death Rates Improving, But Still Higher, In Blacks

February 23, 2007

NCS Heeds Bloch’s Plea, To Consider Establishing Separate PDQ-Like System For General Public Use

December 7, 1984

Zaltrap Receives Positive Opinion For European Market From CHMP

November 30, 2012